1. Home
  2. MHD vs CGEM Comparison

MHD vs CGEM Comparison

Compare MHD & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackrock MuniHoldings Fund Inc.

MHD

Blackrock MuniHoldings Fund Inc.

HOLD

Current Price

$11.86

Market Cap

609.5M

Sector

Finance

ML Signal

HOLD

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

HOLD

Current Price

$10.92

Market Cap

671.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MHD
CGEM
Founded
N/A
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
609.5M
671.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
MHD
CGEM
Price
$11.86
$10.92
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$28.13
AVG Volume (30 Days)
124.9K
1.0M
Earning Date
01-01-0001
02-26-2026
Dividend Yield
4.16%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.92
$5.68
52 Week High
$12.18
$13.33

Technical Indicators

Market Signals
Indicator
MHD
CGEM
Relative Strength Index (RSI) 63.07 55.31
Support Level $11.62 $9.41
Resistance Level $11.77 $10.70
Average True Range (ATR) 0.09 0.63
MACD 0.02 0.03
Stochastic Oscillator 93.94 67.58

Price Performance

Historical Comparison
MHD
CGEM

About MHD Blackrock MuniHoldings Fund Inc.

Blackrock Muniholdings Fund Inc is a diversified, closed-end management investment company. Its investment objective is to provide shareholders with current income exempt from U.S. federal income taxes. The fund mainly invests its managed assets in municipal bonds rated investment grade or, if unrated, are deemed to be of comparable quality by the investment adviser at the time of investment. Its investment portfolio is mainly comprised of long-term municipal bonds with a maturity of more than ten years at the time of investment. The fund can also invest directly in such securities or synthetically through the use of derivatives.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: